FDA Recognizes LSD-Equivalent Drug with ‘Breakthrough Therapy’ Label for Anxiety Relief

High Times
By Sophie Saint ThomasMar 11, 2024, 6:00 am190 pts
Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for treating generalized anxiety disorder (GAD). The designation of “breakthrough therapy” is awarded to expedite…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Top GOP Oklahoma Senator Breaks With Governor Over Call To End Medical Marijuana Program At The Ballot 68

Budtender of the Week : Jason Littlefield 58

Grow Tour: Svin Garden 57

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.